title: FK506--reversal of humorally mediated cardiac allograft rejection in the presence of preformed anti-class I antibody.
authors.affiliation: Department of Surgery, Washington University School of Medicine, Barnes Hospital, St. Louis, Missouri.
authors.forename: E S
authors.initials: ES
authors.lastname: Woodle
authors.forename: D L
authors.initials: DL
authors.lastname: Phelan
authors.forename: J E
authors.initials: JE
authors.lastname: Saffitz
authors.forename: T
authors.initials: T
authors.lastname: Mohanakumar
authors.forename: S
authors.initials: S
authors.lastname: Shenoy
authors.forename: M
authors.initials: M
authors.lastname: Pasque
mesh_terms: D000328:Adult; D000917:Antibody Formation; D005260:Female; D006084:Graft Rejection / Q000276:immunology*; D016027:Heart Transplantation / Q000009:adverse effects*; D015395:Histocompatibility Antigens Class I / Q000276:immunology*; D006801:Humans; D016853:Muromonab-CD3 / Q000627:therapeutic use; D009206:Myocardium / Q000473:pathology; D016559:Tacrolimus / Q000627:therapeutic use*
chemical_list: D015395:Histocompatibility Antigens Class I; D016853:Muromonab-CD3; D016559:Tacrolimus